Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The properties and outcome of an immune response are best predicted by the lymphokine phenotype of the responding T cells. Cytokines produced by CD4+ T helper type 1 (Th1) T cells mediate delayed type hypersensitivity (DTH) and inflammatory responses, whereas cytokines produced by Th2 T cells mediate helper T cell functions for antibody production. To determine whether induction of Th2-like cells would modulate an inflammatory response, interleukin 4 (IL-4) was administered to animals with experimental allergic encephalomyelitis (EAE), a prototypic autoimmune disease produced by Th1-like T cells specific for myelin basic protein (MBP). IL-4 treatment resulted in amelioration of clinical disease, the induction of MBP-specific Th2 cells, diminished demyelination, and inhibition of the synthesis of inflammatory cytokines in the central nervous system (CNS). Modulation of an immune response from one dominated by excessive activity of Th1-like T cells to one dominated by the protective cytokines produced by Th2-like T cells may have applicability to the therapy of certain human autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
Acquisition of lymphokine-producing phenotype by CD4+ T cells
Seder, R. A., & Paul, W. E. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003223 · Cited by 1,557
Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell Clones
Salgame, P., Abrams, J. S., Clayberger, C., Goldstein, H., Convit, J., Modlin, R. L., & Bloom, B. R. (1991) · Science · doi:10.1126/science.1681588 · Cited by 1,028
Immunological Aspects of Demyelinating Diseases
Martin, R., McFarland, H. F., & McFarlin, D. E. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001101 · Cited by 1,010
Seder, R. A., Paul, W. E., Davis, M. M., & Fazekas de St Groth, B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1091 · Cited by 997
Deibler, G. E., Martenson, R. E., & Kies, M. W. (1972) · Preparative Biochemistry · doi:10.1080/00327487208061467 · Cited by 935
"Infectious" Transplantation Tolerance
Qin, S., Cobbold, S. P., Pope, H., Elliott, J., Kioussis, D., Davies, J., & Waldmann, H. (1993) · Science · doi:10.1126/science.8094901 · Cited by 871
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835
Cited by
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 763
Self-citationExperimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice
Wolf, S. D., Dittel, B. N., Hardardottir, F., & Janeway, C. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2271 · Cited by 699
“4, B and C) could be interpreted using Lin’s model in conjunction with the Th1–Th2 immune deviation hypothesis for inflammatory autoimmune disease (37, 38).”
MethodThe Proto-Oncogene c-maf Is Responsible for Tissue-Specific Expression of Interleukin-4
Ho, I.-C., Hodge, M. R., Rooney, J. W., & Glimcher, L. H. (1996) · Cell · doi:10.1016/s0092-8674(00)81299-4 · Cited by 667
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
A proinflammatory role for IL-18 in rheumatoid arthritis
Gracie, J. A., Forsey, R. J., Chan, W. L., Gilmour, A., Leung, B. P., Greer, M. R., Kennedy, K., Carter, R., Wei, X.-Q., Xu, D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7317 · Cited by 636
Huang, D., Wang, J., Kivisakk, P., Rollins, B. J., & Ransohoff, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.713 · Cited by 583
Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3299 · Cited by 556
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 533
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
Segal, B. M., Dwyer, B. K., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.537 · Cited by 469
Self-citationAPC-derived cytokines and T cell polarization in autoimmune inflammation
Gutcher, I., & Becher, B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31720 · Cited by 459
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R., Biedermann, T., Prinz, J., Mack, M., et al. (2003) · Nature Medicine · doi:10.1038/nm804 · Cited by 453
Self-citationLafaille, J. J., Keere, F. V. D., Hsu, A. L., Baron, J. L., Haas, W., Raine, C. S., & Tonegawa, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.307 · Cited by 426
Self-citationAn altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., & Kuchroo, V. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90169-8 · Cited by 412
Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G., & Kollias, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11294 · Cited by 403
A role for sex chromosome complement in the female bias in autoimmune disease
Smith-Bouvier, D. L., Divekar, A. A., Sasidhar, M., Du, S., Tiwari-Woodruff, S. K., King, J. K., Arnold, A. P., Singh, R. R., & Voskuhl, R. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20070850 · Cited by 397
IL-25 regulates Th17 function in autoimmune inflammation
Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B., Langrish, C. L., Chen, Y., Gorman, D. M., Blumenschein, W. M., McClanahan, T., Brombacher, F., Hurst, S. D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061738 · Cited by 396
“In EAE, deviation of the immune system toward a Th2 response correlates with disease resistance (44, 45), and delivery of IL-4 in vivo can modulate the immune response to ameliorate disease (29, 46).”
BackgroundBiedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L., Hültner, L., & Röcken, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1441 · Cited by 395
Self-citationTestosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production
Liva, S. M., & Voskuhl, R. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2060 · Cited by 394
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankensteini, T., Martin, R., Utz, U., Karin, N., Mitchell, D., et al. (1996) · Nature · doi:10.1038/379343a0 · Cited by 379
Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E., & Nicholson, L. B. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081701.141316 · Cited by 366
Feng, X., Xu, W., Li, Z., Song, W., Ding, J., & Chen, X. (2019) · Advanced Science · doi:10.1002/advs.201900101 · Cited by 363
Requirement for Leptin in the Induction and Progression of Autoimmune Encephalomyelitis
Matarese, G., Di Giacomo, A., Sanna, V., Lord, G. M., Howard, J. K., Di Tuoro, A., Bloom, S. R., Lechler, R. I., Zappacosta, S., & Fontana, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5909 · Cited by 355
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Ghoreschi, K., Brück, J., Kellerer, C., Deng, C., Peng, H., Rothfuss, O., Hussain, R. Z., Gocke, A. R., Respa, A., Glocova, I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100977 · Cited by 352
Self-citationThe antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
Sommer, N., Löschmann, P.-A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., et al. (1995) · Nature Medicine · doi:10.1038/nm0395-244 · Cited by 345
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Self-citationThe biology of Stat4 and Stat6
Wurster, A. L., Tanaka, T., & Grusby, M. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203485 · Cited by 309
Müller-Hermelink, N., Braumüller, H., Pichler, B., Wieder, T., Mailhammer, R., Schaak, K., Ghoreschi, K., Yazdi, A., Haubner, R., Sander, C. A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.001 · Cited by 302
Self-citationDolhain, R. J. E. M., van der Heiden, A. N., ter Haar, N. T., Breedveld, F. C., & Miltenburg, A. M. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391204 · Cited by 295
IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice
Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmüller, I., Voigt, H., Launois, P., Levine, A. D., et al. (2001) · Nature Immunology · doi:10.1038/ni725 · Cited by 294
Self-citationDiab, A., Deng, C., Smith, J. D., Hussain, R. Z., Phanavanh, B., Lovett-Racke, A. E., Drew, P. D., & Racke, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2508 · Cited by 291
Self-citationAutoimmune thyroid disease: new models of cell death in autoimmunity
Stassi, G., & De Maria, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri750 · Cited by 284
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Yang, Y., Weiner, J., Liu, Y., Smith, A. J., Huss, D. J., Winger, R., Peng, H., Cravens, P. D., Racke, M. K., & Lovett-Racke, A. E. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082584 · Cited by 282
Self-citationTh1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus
Akahoshi, M., Nakashima, H., Tanaka, Y., Kohsaka, T., Nagano, S., Ohgami, E., Arinobu, Y., Yamaoka, K., Niiro, H., Shinozaki, M., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1644::aid-anr12>3.0.co;2-l · Cited by 279
Aloisi, F., Ria, F., Penna, G., & Adorini, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4671 · Cited by 276
The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
Prud'homme, G. J., & Piccirillo, C. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0339 · Cited by 276
La Flamme, A. C., Ruddenklau, K., & Bäckström, B. T. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.4996-5004.2003 · Cited by 265
IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease
Röcken, M., Racke, M., & Shevach, E. M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80556-1 · Cited by 264
Self-citationThe role of IL-12 in the induction of organ-specific autoimmune diseases
Trembleau, S., Adorini, L., Germann, T., & Gately, M. K. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80006-9 · Cited by 263
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis
Holdsworth, S. R., Kitching, A. R., & Tipping, P. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00369.x · Cited by 262
Th1/Th2 cytokine balance in arthritis
Miossec, P., & Berg, W. V. D. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401203 · Cited by 257
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization
Sewell, D. (2003) · International Immunology · doi:10.1093/intimm/dxg012 · Cited by 254
Cantorna, M. T. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22333.x · Cited by 252
Waisman, A., Ruiz, P. J., Hirschberg, D. L., Gelman, A., Oksenberg, J. R., Brocke, S., Mor, F., Cohen, I. R., & Steinman, L. (1996) · Nature Medicine · doi:10.1038/nm0896-899 · Cited by 237
Miller, A., Shapiro, S., Gershtein, R., Kinarty, A., Rawashdeh, H., Honigman, S., & Lahat, N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00191-x · Cited by 225
Comabella, M., Balashov, K., Issazadeh, S., Smith, D., Weiner, H. L., & Khoury, S. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3125 · Cited by 221
“In the experimental autoimmune encephalomyelitis (EAE) mouse model, T cells producing Th1 cytokines can transfer disease (5, 6), while spontaneous recovery from EAE correlates with a switch to TGFb and Th2 cytokines (7–10).”
BackgroundHoward, L. M., Miga, A. J., Vanderlugt, C. L., Canto, M. C. D., Laman, J. D., Noelle, R. J., & Miller, S. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5388 · Cited by 217
“First, DTH responsiveness, a measure of in vivo generation of Th1 cells (44), to both the initiating and relapseassociated PLP epitopes is significantly reduced in antiCD154–treated mice (Fig.”
BackgroundCytokines in multiple sclerosis: from bench to bedside
IMITOLA, J., CHITNIS, T., & KHOURY, S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.007 · Cited by 215
The other side of the coin: The protective role of the TH2 cytokines
Finkelman, F. D., & Urban, J. F. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.114989 · Cited by 195
Expansion of Autoreactive T Cells in Multiple Sclerosis Is Independent of Exogenous B7 Costimulation
Scholz, C., Patton, K. T., Anderson, D. E., Freeman, G. J., & Hafler, D. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1532 · Cited by 194
“This is of particular interest as IL-4 secretion by MBP-reactive T cells has been shown to ameliorate EAE induced by activated MBP-reactive T cells (33).”
Guenova, E., Skabytska, Y., Hoetzenecker, W., Weindl, G., Sauer, K., Tham, M., Kim, K.-W., Park, J.-H., Seo, J. H., Ignatova, D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416922112 · Cited by 191
“To the contrary, the number of peripheral IFN-γCD4 TH1 cells or serum IFN-γ even increase after IL-4 administration in mice with EAE (11), hemophagocytic lymphohistiocytosis (17), or hapteninduced contact hypersensitivity (15), and in humans with psoriasis (16); mice with transgenic overexpression of IL-4 exhibit TH2-…”
BackgroundInfluentialSelf-citationSilencing T-bet Defines a Critical Role in the Differentiation of Autoreactive T Lymphocytes
Lovett-Racke, A. E., Rocchini, A. E., Choy, J., Northrop, S. C., Hussain, R. Z., Ratts, R. B., Sikder, D., & Racke, M. K. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.010 · Cited by 183
“Shifting the phenotype of my-but to a lesser extent in most other IFN -producing elin-reactive T cells from a Th1 to a Th2 phenotype iscells, T-bet may be a target for therapeutics for Th1beneficial in the treatment of EAE (Racke et al., 1994,mediated diseases.”
BackgroundMethodInfluentialSelf-citationImmunopathogenesis and role of T cells in psoriasis
Ghoreschi, K., Weigert, C., & Röcken, M. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.08.012 · Cited by 179
Self-citationMolina‐Holgado, E., Vela, J. M., Arévalo‐Martín, A., & Guaza, C. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01412.x · Cited by 163
The Role of Helper T Cell Subsets in Autoimmune Diseases
Lafaille, J. J. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00009-4 · Cited by 160
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Brück, J., Dringen, R., Amasuno, A., Pau‐Charles, I., & Ghoreschi, K. (2018) · Experimental Dermatology · doi:10.1111/exd.13548 · Cited by 128
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
S., P. A. (2006) · doi:10.4049/jimmunol.176.7.4385 · Cited by 80
“The exogenous administration of IL-4 after adoptive transfer of MBP-reactive cells attenuated the disease severity in EAE animals (25).”
BackgroundSystemic treatments for allergic contact dermatitis
Sung, C. T., McGowan, M. A., Machler, B. C., & Jacob, S. E. (2019) · Dermatitis® · doi:10.1097/der.0000000000000435 · Cited by 31
Metadata
- Authors
- Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M., & Röcken, M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-11-01
- Volume
- 180
- Issue
- 5
- Pages
- 1961-1966
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2029146247
- Cited by
- 594
- References
- 34
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.